에 대한 최신 뉴스 Merck (OTC:MKKGY) 주식

Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Uber Weride

Equities

Mid Cap

News

Movers

Trading Ideas

AXSM

CRSP

MKGAF

MKKGY

NVDA

RXRX

SWTX

TEVA

VNET

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 위라이드(NASDAQ:WRD)의 주식이 97.62% 급등했다. 이는 엔비디아(NASDAQ:NVDA)가 13F 제출을 통해 174만 주의 지분을 보유하고 있다고 공개한 후 발생한 일이다.

위라이드, 크리스퍼 및 진DX 등 지난주 최대 상승한 10개의 중형주 (2월 10일-2월 14일)

Merck KGaA

Mattel's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NYSE">MAT</a>) short percent of float has fallen 13.87% since its last report. The company recently reported that it has 12.22 million shares sold short, which is 6.15% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.88 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Mattel Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747843230_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Mattel has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Mattel's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Mattel's peer group average for short interest as a percentage of float is 9.42%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Mattel's Recent Short Interest

Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) has outperformed the market over the past 20 years by 1.61% on an annualized basis producing an average annual return of 9.94%. Currently, Universal Health Services has a market capitalization of $12.60 billion. 
Buying $100 In UHS: If an investor had bought $100 of UHS stock 20 years ago, it would be worth $665.00 today based on a price of $195.50 for UHS at the time of writing.
<h3>Universal Health Services's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747843229_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Universal Health Services 20 Years Ago Would Be Worth This Much Today

In the current market session, Sprouts Farmers Market Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) stock price is at $165.12, after a 1.73% decrease. However, over the past month, the company's stock went up by 0.27%, and in the past year, by 104.64%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1747843228_0.png" alt="Past Year Chart" />

<h3>Sprouts Farmers Market P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Sprouts Farmers Market has a better P/E ratio of 37.84 than the aggregate P/E ratio of 33.0 of the Consumer Staples Distribution &amp; Retail industry. Ideally, one might believe that Sprouts Farmers Market Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1747843228_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

P/E Ratio Insights for Sprouts Farmers Market

Ovintiv's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) short percent of float has risen 4.31% since its last report. The company recently reported that it has 8.92 million shares sold short, which is 3.87% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.29 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Ovintiv Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747843225_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ovintiv has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ovintiv's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Ovintiv's peer group average for short interest as a percentage of float is 7.98%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on Ovintiv?

Novavax's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NYSE">NVAX</a>) short percent of float has fallen 17.46% since its last report. The company recently reported that it has 42.33 million shares sold short, which is 26.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.4 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Novavax Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747843220_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Novavax has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Novavax's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Novavax's peer group average for short interest as a percentage of float is 16.62%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

NVAX

What's Driving the Market Sentiment Around Novavax?

Scotiabank analyst Himanshu Gupta maintains Nexus Ind REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/NXR#TSX">NXR</a>) with a Sector Perform and raises the price target from C$7 to C$7.5.

Price Target

Analyst Ratings

TSX:NXR

TSX:NXR/UN

Scotiabank Maintains Sector Perform on Nexus Ind REIT, Raises Price Target to C$7.5

Scotiabank analyst Nick Altmann maintains Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) with a Sector Perform and raises the price target from $19 to $26.

NCNO

Scotiabank Maintains Sector Perform on Ncino, Raises Price Target to $26

Scotiabank analyst Nicholas Yulico maintains Federal Realty Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRT#NYSE">FRT</a>) with a Sector Outperform and raises the price target from $111 to $113.

Scotiabank Maintains Sector Outperform on Federal Realty Investment, Raises Price Target to $113

Scotiabank analyst Sung Ji Nam maintains Castle Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) with a Sector Outperform and lowers the price target from $44 to $40.

CSTL

Scotiabank Maintains Sector Outperform on Castle Biosciences, Lowers Price Target to $40

OFAL

OFA Group Shares Halted On Circuit Breaker To The Upside At $8.59/Share

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) soared to a new all-time high on Wednesday, crossing $109,000 amid rising investor confidence and renewed momentum in <a href="https://www.benzinga.com/money/bitcoin-price-prediction#:~:text=By%202025%2C%20Bitcoin%20is%20projected,projecting%20prices%20upwards%20of%20%24180%2C000.">the digital asset market</a>.
What Happened: Bitcoin&#8217;s new high of $109,500 on Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), surpasses the previous record set in January, underlining Bitcoin's resilience and growing role in macro portfolios.
The world's largest cryptocurrency has staged a sharp recovery from its April 8 low of $76,320, a day that coincided with a broader downturn in equities driven by fears of a renewed U.S. trade conflict. 
Since then, Bitcoin has rebounded over 40%, bolstered by both technical momentum and a favorable macroeconomic environment.
More than $50 million in short positions were liquidated within a single hour as the rally gathered steam, signaling a wave of forced buying and renewed bullish sentiment. 
The surge in price is accompanied by fundamental strength: over 33,000 BTC were added to short-term holder supply in just the past week, while long-term holders have quietly accumulated nearly half a million BTC since March.
What experts Are Saying: Bitcoin's rise comes at a time when digital assets are increasingly diverging from traditional risk markets.
"This isn&#8217;t just noise—it's conviction," Iliya Kalchev, analyst at Nexo Dispatch told Benzinga. "We're seeing a reshuffling of the supply landscape that supports durable upside rather than a speculative spike."
As global investors reassess their exposure to U.S. equities amid trade tensions and inflation uncertainty, assets like Bitcoin have drawn inflows as potential hedges and alternative stores of value. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45543096/why-donald-trump-including-cardano-in-the-crypto-reserve-suprised-even-the-founder-nice-to-see-progress">Why Donald Trump Including Cardano In The Crypto Reserve Suprised Even The Founder: &#8216;Nice To See Progress&#8217;</a>
Standard Chartered had previously forecast <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45034209/bitcoin-could-hit-120000-in-q2-says-standard-chartereds-geoff-kendrick">a fresh high in Q2</a>, citing increased asset reallocation among institutional players.
While altcoins like Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>), and Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) also posted modest gains of 1–3%, the spotlight remained firmly on Bitcoin. 
Meanwhile, the U.S. Securities and Exchange Commission has postponed decisions on several new exchange-traded fund proposals tied to major altcoins, including XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), DOGE and SOL, delaying the potential next wave of ETF-driven market expansion.
Gadi Chait, Investment Manager at Xapo Bank, emphasized that Bitcoin's current momentum is underpinned by spot market participation. 
"Funding rates on Binance remained negative through early May, and neutral funding yields have compressed sharply," he told Benzinga. "That indicates fresh capital entering without overleveraged froth."
Chait also pointed to a rare convergence of supportive macro and policy factors. "We've got a temporary cooling of U.S.–China tariff escalation, softer inflation prints, and the first real bipartisan tailwind in Washington with the FIT21 bill. 
At the same time, the UK's regulatory framework is nearing final form. All of this creates room for allocators to reenter the market."
What&#8217;s Next: Institutional participation is no longer marginal.
BlackRock's spot Bitcoin ETF IBIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>), recently exceeded $62 billion in assets under management, reinforcing Bitcoin's evolving status as a mainstream investment instrument.
Traders are closely watching the $108,000 support level for confirmation of continued bullish momentum. 
A decisive break higher could propel Bitcoin toward $110,000 in the coming days. 
Macro watchers are also awaiting speeches from Federal Reserve officials and key U.S. economic data later this week for clues on future monetary policy.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45534496/altcoin-rotation-is-coming-expert-says-will-eth-xrp-dogecoin-benefit">Altcoin Rotation Is Coming, Expert Says: Will ETH, XRP, Dogecoin Benefit?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$BTC

$DOGE

$SOL

$XRP

COIN

IBIT

Bitcoin Hits All-Time High Of $109,500: What's Next?

ChargePoint Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher on Wednesday</a> after the firm revealed a strategic collaboration with Eaton, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45540209/chargepoint-and-eaton-establish-industry-first-ev-charging-partnership" rel="noreferrer noopener">a leading power management firm</a>.
The partnership aims to speed up the rollout of electric vehicle charging infrastructure across North America and Europe by offering integrated solutions that combine EV chargers, power systems, and engineering services. The effort is designed to simplify project execution while minimizing costs for customers.
Under the alliance, ChargePoint and Eaton will collaborate to create end-to-end electrification solutions, including advancements in bidirectional power flow and vehicle-to-everything (V2X) technology. This will enable EVs to operate as mobile energy hubs, powering homes, commercial buildings, and more.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/45164220" rel="noreferrer noopener">EVgo Vs. ChargePoint: Tariffs, Technicals, And The Road To Profitability</a>
By integrating EV chargers and supporting infrastructure, the companies intend to make it easier for organizations to electrify their fleets and facilities.
The collaboration positions ChargePoint to deliver a full-service EV ecosystem, bridging gaps between vehicles, charging networks, and energy grids through its cloud-based software platform.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, CHPT stock has lost over 57% in the past year. Investors can gain exposure to the stock via&nbsp;WisdomTree Trust WisdomTree Battery Value Chain and Innovation Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/WBAT#BATS">WBAT</a>).
&#8220;ChargePoint&#8217;s partnership with Eaton will deliver innovation that addresses the biggest barriers to electrified transportation,&#8221; said Rick Wilmer, ChargePoint&#8217;s CEO.
Paul Ryan, General Manager of Energy Transition at Eaton, said the customers habitually turn to Eaton for solutions to their most complex power management challenges, and this partnership is set to directly address that need for vehicle charging, bringing together trusted power distribution and EV charging solutions to simplify electrification at scale.
Price Action: CHPT shares are trading higher by 2.56% to $0.7231&nbsp;at last Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/45380207" target="_blank" rel="noreferrer noopener">Plug Power Chases Growth Beyond US Tax Credit Hurdles</a></li>
</ul>
Image by YuniqueB via Shutterstock

General

CHPT

WBAT

What's Going On With ChargePoint Stock On Wednesday?

When your dad is one of the richest people on the planet, you might assume you'd never have to worry about scraping together money for home repairs—especially not for something as practical as a kitchen remodel. But for Warren Buffett's daughter, Susie Buffett., the rules were different. She wasn't looking for a handout. She was asking for a loan—and still got a hard no.
The story was first shared publicly in a 2006 interview on "Good Morning America," where Susie <a href="https://www.benzinga.com/personal-finance/25/04/44889632/warren-buffetts-son-cashed-in-90k-instead-of-waiting-on-500-million-now-hes-using-buffett-bucks-to-build-his-own-dream-town-in-new-york">appeared with her siblings</a>. She mentioned asking her father for a loan to remodel her kitchen after having a baby.
A few years later, Toronto's <a href="https://www.theglobeandmail.com/life/relationships/peter-buffetts-rich-life-doesnt-come-from-family-wealth/article4255258/">Globe and Mail followed up</a> with a 2011 feature reporting that Susie had requested $41,000—and that her father told her to "go to the bank like everyone else."
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
That moment became somewhat legendary, especially for those familiar with Buffett's tough-love approach to money. In the 2017 <a href="https://www.hbo.com/movies/becoming-warren-buffett-2017">HBO documentary, ‘Becoming Warren Buffett</a>," Susie revisited the story, saying, "There's the famous story about the kitchen with me. I had some trouble with that one just because I thought I was asking for a loan. I was not asking him to give me the money. I thought, oh come on, can't you do this?"&nbsp;
She <a href="https://www.benzinga.com/personal-finance/25/01/43166526/billionaire-warren-buffetts-first-wife-said-he-cared-about-the-win-not-the-money-its-all-mental-with-him-and-money-is-his-scorecard">joked to her mother</a> that she'd end up "on the cover of People magazine someday homeless, because my dad will be like this super rich guy and… we'll all be wandering around."
The most detailed version of the story comes from Alice Schroeder's 2008 authorized biography, "The Snowball: Warren Buffett and the Business of Life." According to Schroeder, Susie and her husband Allen were living in a cramped Washington, D.C., home with "a kitchen the size of a baby blanket." They planned a modest renovation to make room for a kitchen table and access to their garden.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
When she asked her billionaire father for a loan, Buffett replied, "Why not go to the bank?" He went on to explain that just as a quarterback shouldn't start for Nebraska just because his dad played the position, children shouldn't be handed advantages they haven't earned. "He won't give it to us on principle," Susie said. "All my life, my father has been teaching us. Well, I feel I've learned the lesson. At a certain point, you can stop" .
From an investment perspective, the lesson is crystal clear. Buffett has never viewed capital as something to be given freely—even to those closest to him. He believed in value, in proving your case, and in capital allocation with discipline, whether you're a Fortune 500 CEO or his own daughter asking for a modest loan.
See Also: The team behind $6B+ in licensing deals is now building the next billion-dollar IP empire — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">invest early at $2.25/share.</a>
In a way, this story isn't just about a kitchen. It's about Buffett's guiding principle: money isn't about love—it's about responsibility.&nbsp;
Buffett had no problem giving billions to global health, education, and poverty initiatives. But when it came to his children, he drew a firm line between charity and family support. For him, financial self-sufficiency was a non-negotiable—<a href="https://www.benzinga.com/personal-finance/25/03/44574657/billionaire-warren-buffetts-son-says-everyone-assumes-hes-rich-8-out-of-10-messages-a-day-are-just-people-wanting-something-from-my-dad">no matter your last name</a>.
And while the anecdote <a href="https://www.benzinga.com/personal-finance/25/03/44482365/warren-buffetts-son-wasnt-raised-like-a-billionaires-kid-he-mowed-lawns-and-cleaned-gutters-because-there-are-jerks-with-money-and-jerks-without">reads like a parenting parable</a>, it's also a page straight from the Buffett investing ethos: discipline trumps emotion, even when it's close to home.&nbsp;
Read Next:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Billionaire Warren Buffett's Daughter Asked Him For A $41,000 Loan To Remodel Her Tiny Kitchen — His Response: 'Why Not Go To The Bank?'

Scotiabank analyst Sung Ji Nam maintains Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) with a Sector Outperform and lowers the price target from $3 to $2.

BDSX

Scotiabank Maintains Sector Outperform on Biodesix, Lowers Price Target to $2

OFA Group Shares Halted On Circuit Breaker To The Upside At $7.81/Share

Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) has outperformed the market over the past 15 years by 12.74% on an annualized basis producing an average annual return of 24.56%. Currently, Booking Holdings has a market capitalization of $173.33 billion. 
Buying $1000 In BKNG: If an investor had bought $1000 of BKNG stock 15 years ago, it would be worth $27,682.26 today based on a price of $5326.62 for BKNG at the time of writing.
<h3>Booking Holdings's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747842312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BKNG

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Shares of Palo Alto Networks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) continued to slide after the company reported its fiscal third-quarter results on Tuesday.
Here are some key analyst takeaways.
Goldman Sachs On Palo Alto Networks
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/589dc33e43eaaa000122c59a/gabriela-borges">Analyst Gabriela Borges</a> maintained a Buy rating while raising the price target from $215 to $231.
Palo Alto Networks reported a mixed quarter, with RPO and revenue in line with Street expectations, while EBIT margin and earnings beat estimates by 30 basis points (bps) and 3%, respectively, Borges said in a note. Management raised their full-year revenue, earnings, and margin projections to the high end of their prior guidance, she added.
The company noted that deal activity was impacted by macro uncertainty in early April, but the deal cycle normalized later in the month and into May, the analyst stated. "While we expect to see a number of next-gen vendors in AI security, we ultimately believe that this field will consolidate over time in favor of leaders such as Palo Alto, that have the ability and willingness to invest in technology leadership, outsource R&amp;D via M&amp;A, and realize attractive unit economics from cross sell," she further wrote.
TD Cowen On Palo Alto Networks
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5968f79c988ca80001cea41a/shaul-eyal">Analyst Shaul Eyal</a> reiterated a Buy rating and price target of $230.
Palo Alto Networks' NGS ARR (next-generation security annual recurring revenue) grew by 34% year-on-year to $5.09 billion, exceeding the consensus of $5.06 billion, while RPO (remaining performance obligation) rose 19.5% year-on-year to $13.5 billion, almost in line with expectations, Eyal said. The company generated revenue growth of 15% year-on-year, taking its top line to $2.29 billion, above the consensus of $2.28 billion, he added.
The analyst stated that the results reflect "ongoing healthy platformization performance" and strong adoption of AI solutions in the fiscal third quarter. Palo Alto Networks has a robust pipeline for the fourth quarter, "lending itself for a strong FY25 finish," he wrote.
Piper Sandler On Palo Alto Networks
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/590783e6290fa70001409b4a/rob-owens">Analyst Rob Owens</a> reaffirmed a Neutral rating and price target of $200.
Owens said Palo Alto Networks recorded operating margins of 27.4%, beating consensus by around 30 bps. This took earnings to 80 cents per share, 3 cents per share higher than the top end of its guidance range.
However, bookings growth decelerated sequentially to 9%, from 15% in the previous quarter, the analyst stated. While the company said it faced uncertainty during April due to "geopolitical shifts," this has "largely subsided since," he further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
KeyBanc Capital Markets On Palo Alto Networks
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/62eacb8a9bab060001dbd41a/eric-heath">Analyst Eric Heath</a> maintained an Overweight rating and price target of $220.
For the fiscal fourth quarter, Palo Alto Networks guided to revenues of $2.49-$2.51 billion, representing 14%-15% year-on-year growth, almost in line with consensus, Heath said. Its RPO guidance of $15.2-$15.3 billion incorporates 20% year-on-year growth, similar to the previous quarter, he added.
The analyst stated that the company raised its revenue guidance for the full year by $15 million to $9.17-$9.19 billion, up 14% and beating the consensus of $9.166 billion. NSG momentum remained robust, with "notable strength" from XSIAM (extended security intelligence and automation management).
JMP Securities On Palo Alto Networks
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6298be750c34880001d668d9/trevor-walsh">Analyst Trevor Walsh</a> reiterated a Market Outperform rating and a price target of $212.
Palo Alto Networks reported its quarterly results modestly better than expected, Walsh said. The company guided to non-GAAP earnings of 87-89 cents per share for the fiscal fourth quarter, above consensus of 86 cents per share, he added.
Management indicated that "rapid and widespread" AI adoption was not only driving "the need to secure AI-specific resources but also further accelerating broader IT transformations, such as the transition to the cloud," the analyst further wrote.
Guggenheim Securities On Palo Alto Networks
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587f78d077f9dd000126ef0f/john-difucci">Analyst John DiFucci</a> reaffirmed a Sell rating and price target of $130.
Palo Alto Networks' results were mixed, "with revenue about a half percent above the consensus number, driven by Product outperformance and partially offset by subscription underperformance," DiFucci said. The company maintained its full-year NGS ARR and RPO guidance, indicating growth between 31%-32% and 19%-20%, respectively, he added.
"Management acknowledged April weakness post Liberation Day, though this has leveled out, but not before resulting in dampened F3Q25 results, which carried over to mixed F4Q25 guidance (that may include some acquired Protect AI contribution that should close by F1Q)," the analyst wrote.
RBC Capital Markets On Palo Alto Networks
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5880b6f377f9dd00011b0ab2/matthew-hedberg">Analyst Matthew Hedberg</a> maintained an Outperform rating and a price target of $232.
Palo Alto Networks reported solid results, despite some tariff related macro disruption in the quarter, Hedberg said. He added, however, that the macro environment normalized into May.
The company generated an AI ARR of $400 million, up from $250 million in the first quarter, and recorded an average ARR per customer of more than $1 million for XSIAM, the analyst stated. "Overall, we like the large-deal and newer product momentum fueling NGS ARR growth." 
PANW Price Action: At the time of publication on Wednesday, shares of Palo Alto Networks had declined by 5.99% to $182.83.
Read More: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst">T-Mobile, Palo Alto Partner To Enhance 5G Cybersecurity For US Businesses</a>
Photo: Shutterstock

Analyst Color

Earnings Beats

Reiteration

PANW

Palo Alto Networks Posts Solid 3Q, Next Gen Security Momentum Strong Despite Macro Uncertainty

OFA Group Shares Resume Trading

<a href="https://www.semafor.com/article/05/21/2025/nvidia-ceo-says-us-chip-export-controls-on-china-are-a-failure">https://www.semafor.com/article/05/21/2025/nvidia-ceo-says-us-chip-export-controls-on-china-are-a-failure</a>

'Nvidia CEO says US chip export controls on China are a 'failure''- Semafor

JP Morgan analyst David Karnovsky maintains Tegna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGNA#NYSE">TGNA</a>) with a Neutral and lowers the price target from $19 to $18.

TGNA

JP Morgan Maintains Neutral on Tegna, Lowers Price Target to $18

Press Releases

ASNA and Athinia® collaborate to boost semiconductor manufacturing yields through improved data sharing and traceability of subcomponent parts

PLTR

Merck

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 위라이드(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>)의 주식이 97.62% 급등했다. 이는 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)가 13F 제출을 통해 174만 주의 지분을 보유하고 있다고 공개한 후 발생한 일이다.
2. GDS 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>)의 주식이 43.45% 상승했다. 이는 트럼프 대통령이 중국에서 오는 $800 이하의 소포에 대한 관세를 연기했다고 보도된 후 발생한 일이다. 또한, 중국의 딥시크(DeepSeek) AI 모델에 대한 낙관론도 최근 주가를 끌어올렸다.
3. 스프링웍스 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>)의 주식이 42.58% 상승했다. 이는 머크 그룹(OTC:<a class="ticker" href="https://www.benzinga.com/stock/MKGAF#OTC">MKGAF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MKKGY#OTC">MKKGY</a>)가 회사를 인수하기 위한 고급 논의를 진행 중이라고 발표한 후 발생한 일이다.
4. 리커젼 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>)의 주식이 40.59% 증가했다.
5. 세이블 오프쇼어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOC#NYSE">SOC</a>)의 주식이 39.09% 상승했다.
6. 진DX 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>)의 주식이 28.23% 상승했다. 이는 회사가 울트라래피드 전장유전체 시퀀싱(UltraRapid Whole Genome Sequencing)을 발표하여 48시간 내에 실행 가능한 결과를 제공한다고 발표한 후 발생한 일이다.
7. 브이넷 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNET#NASDAQ">VNET</a>)의 주식이 28.22% 상승했다. 이는 지난 주 중국의 딥시크 AI 모델과 관련된 AI 경쟁 우려로 하락한 후 반등 가능성이 제기된 것으로 보인다.
8. 인스페리티(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>)의 주식이 25.99% 증가했다. 이는 회사가 예상보다 좋은 4분기 결과를 발표한 후 발생한 일이다.
9. 크리스퍼 테라퓨틱스 AG(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>)의 주식이 25.21% 상승했다. 이는 회사가 예상보다 좋은 4분기 재무 결과를 발표한 후 여러 애널리스트들이 주가 전망을 상향 조정한 후 발생한 일이다.
10. 액섬 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>)의 주식이 24.01% 상승했다. 이는 회사가 테바 파마슈티컬(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>)과의 모든 특허 소송을 해결하기 위한 합의에 도달한 후 발생한 일이다. 여러 애널리스트들이 주가 전망을 상향 조정했다.
다음 읽기:
<a href="https://kr.benzinga.com/news/usa/stocks/%EC%8A%88%ED%8D%BC-%EB%A7%88%EC%9D%B4%ED%81%AC%EB%A1%9C-%EC%9D%B8%ED%85%94-%EC%95%8C%EB%A6%AC%EB%B0%94%EB%B0%94-%EB%B0%8F-cvs-%EB%93%B1-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%83%81%EC%8A%B9%ED%95%9C-12/" target="_blank" rel="noopener">슈퍼 마이크로, 인텔, 알리바바 및 CVS 등 지난주 상승한 12개 대형주 (2월 10일-2월 14일)</a>
<a href="https://kr.benzinga.com/news/usa/stocks/%EB%A0%88%EB%94%A7-%EA%B3%A0%EB%8C%80%EB%94%94-%EB%B0%8F-%ED%8A%B8%EB%A0%88%EC%9D%B4%EB%93%9C-%EB%8D%B0%EC%8A%A4%ED%81%AC%EB%8A%94-%EB%93%B1-%EC%A7%80%EB%82%9C%EC%A3%BC-%ED%95%98%EB%9D%BD%ED%95%9C-11/" target="_blank" rel="noopener">레딧, 고대디 및 트레이드 데스크는 등 지난주 하락한 11개의 대형주 (2월 10일~2월 14일)</a>
사진 출처: WeRide
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Merck

뉴스

에 대한 최신 뉴스 Merck (OTC:MKKGY) 주식

일요일, 2월 16, 2025

뉴스

파트너 / 기고자

벤징가 글로벌